Anti-troponin autoantibodies and the cardiovascular system

Heart

Volumn 96, Issue 19, 2010, Pages 1518-1524

  Nussinovitch, U ^a   Shoenfeld, Yeshuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; IMMUNOGLOBULIN; TROPONIN; TROPONIN ANTIBODY; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; IMMUNOADSORPTION; MYOCARDITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER;

ANIMALS; AUTOANTIBODIES; CARDIOMYOPATHIES; FORECASTING; HUMANS; IMMUNOTHERAPY; MICE; TROPONIN;

EID: 77957300074     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.195255     Document Type: Review

References (42)

1. Shoenfeld Y, Gilburd B, Abu-Shakra M, et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 2008;10:3-7. (Pubitemid 351649454)
2. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseasese2008. Isr Med Assoc J 2008;10:8-12. (Pubitemid 351649455)
3. Nussinovitch U, Shoenfeld Y. Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp (Warsz) 2009;57:95-104.
4. Nussinovitch U, Shoenfeld Y. [Autoimmune mechanisms in cardiovascular diseases]. Harefuah 2009;148:173-6, 210.
5. Jahns R, Boivin V, Lohse MJ. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 2006;112:7-14. (Pubitemid 44247194)
6. Brucato A, Maestroni S, Cumetti D, et al. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 2008;8:44-7.
7. Gershwin ME. The mosaic of autoimmunity. Autoimmun Rev 2008;7:161-3.
8. Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun Rev 2008;7:209-13.
9. Shoenfeld Y, Blank M, Abu-Shakra M, et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 2008;10:13-19.
10. Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 2007;7:42-5.
11. Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 2008;7:616-20.
12. Jahns R, Boivin V, Schwarzbach V, et al. Pathological autoantibodies in cardiomyopathy. Autoimmunity 2008;41:454-61.
13. Leuschner F, Li J, Goser S, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008;29:1949-55.
14. Shmilovich H, Danon A, Binah O, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 2007;117:198-203.
15. Bohner J, von Pape KW, Hannes W, et al. False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies. Clin Chem 1996;42:2046.
16. Okazaki T, Tanaka Y, Nishio R, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9:1477-83.
17. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005;352:98-100.
18. Landsberger M, Staudt A, Choudhury S, et al. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Am Heart J 2008;156:92-9. e2.
19. Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann NY Acad Sci 2009;1173:67-74.
20. Adamczyk M, Brashear RJ, Mattingly PG. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem 2009;55:1592-3.
21. Adamczyk M, Brashear RJ, Mattingly PG. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem 2010;56:676-7.
22. Kaya Z, Goser S, Buss SJ, et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008;118:2063-72.
23. Goser S, Andrassy M, Buss SJ, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-702.
24. Kaya Z, Katus HA, Rose NR. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 2010;134:80-8.
25. Lappe JM, Pelfrey CM, Tang WH. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 2008;14:521-30.
26. Eriksson S, Ilva T, Becker C, et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 2005;51:848-55. (Pubitemid 40577920)
27. Eriksson S, Halenius H, Pulkki K, et al. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005;51:839-47.
28. Latva-Hirvela J, Kyto V, Saraste A, et al. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis. Eur J Clin Invest 2009;39:457-62.
29. Baba A. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy. Ther Apher Dial 2008;12:109-16.
30. Nussinovitch U, Shoenfeld Y. Autoimmune dilated cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M, eds. Diagnostic criteria in autoimmune diseases. New Jersey, USA: The Humana Press Inc, 2008:367-72.
31. Miettinen KH, Eriksson S, Magga J, et al. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail 2008;14:481-8.
32. Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-22.
33. Niebroj-Dobosz I, Marchel M, Madej A, et al. Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy. Acta Myol 2008;27:1-6.
34. Dungen HD, Platzeck M, Vollert J, et al. Autoantibodies against cardiac troponin I in patients with congestive heart failure. Eur J Heart Fail 2010; 12:668-75.
35. Li HS, Ligons DL, Rose NR. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 2008;7:168-73.
36. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113:1071-8. (Pubitemid 43754273)
37. Pettersson K, Eriksson S, Wittfooth S, et al. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009;55:938-45.
38. Nussinovitch U, Shoenfeld Y. Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases. Autoimmun Rev 2008;7:445-52.
39. Muller J, Wallukat G, Dandel M, et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000;101:385-91.
40. Doesch AO, Konstandin M, Celik S, et al. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. J Clin Apher 2009;24:141-9.
41. Frenkel D, Pachori AS, Zhang L, et al. Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. Int Immunol 2009;21:817-29.
42. Plebani M, Mion M, Altinier S, et al. False-positive troponin I attributed to a macrocomplex. Clin Chem 2002;48:677-9.